Menu
Recruiting NCT07561905

Tampon Safety-in-Use Study

No phase Interventional Menstruation

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Tampon A.
Who it may be relevant to
Registry conditions: Menstruation. Basic parameters: 18 years — 49 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

An Open-Label Applicator Tampon Safety-in-Use Study

Overview

The goal of this clinical trial is to confirm the safety of a tampon in healthy female volunteers. Participants will use the study tampons as they normally would for one menstrual cycle. Gynecological exams will be conducted before and after the menstrual cycle.

Interventions

  • Device Tampon A
    Commercially available tampons in regular, super, and super plus absorbencies

Primary outcome measures

  • Incidence of Tampon Related Adverse Events [Time frame: From enrollment to 7 days post last visit]

Eligibility criteria

Inclusion criteria

  • Willing and able to read and provide written informed consent.
  • Female in good general health, age 18-49 (inclusive).
  • History of regular menstrual cycles during the previous 3months lasting approximately 21-35 days, including at least 4 days of menstruation, and expecting to menstruate during the study period.
  • History of use of applicator tampons within the past 12 months without discomfort.
  • Tracks menstruation and be able to confidently predict onset of menstruation
  • Normally use at least 6 tampons for protection during menstruation.
  • Normally uses regular, super, and/or super plus absorbency tampons for menstrual protection.
  • Agrees to the conduct of all study procedures, including gynecological exams and agrees to follow all study instructions and return for scheduled appointments.
  • Has used an acceptable form of birth control for at least one month prior to enrollment and for the duration of the study.

Exclusion criteria

  • Pregnant, lactating or is trying to become pregnant.
  • Less than six (6) weeks post-partum.
  • Has a menstrual abnormality (such as oligomenorrhea or amenorrhea).
  • Has a known allergy or sensitivity to components of the investigational products
  • Any other medical condition or history, as determined by the Investigator that could compromise the study results or subject safety.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Other

Study locations

United States · 1 center
  • Princeton Consumer Research — St. Petersburg

Identifiers

NCT: NCT07561905 · CNS-2026-0003

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗